Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (DEFICIT) (UNAUDITED)

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) (UNAUDITED) - USD ($)
Total
Common Stock Warrants
Prefunded Warrants
Common Stock
Common Stock
Common Stock Warrants
Common Stock
Prefunded Warrants
Additional Paid-In Capital
Additional Paid-In Capital
Common Stock Warrants
Additional Paid-In Capital
Prefunded Warrants
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020       288,074,415            
Beginning balance at Dec. 31, 2020 $ 450,786     $ 288,074     $ 38,896,693     $ (38,733,981)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation expense (in shares)       600,000            
Stock-based compensation expense 146,580     $ 600     145,980      
Exercise warrant (in shares)         67,166,667 11,800,000        
Exercise warrant   $ 4,030,000 $ 11,800   $ 67,167 $ 11,800   $ 3,962,833    
Net loss (2,160,517)                 (2,160,517)
Ending balance (in shares) at Mar. 31, 2021       367,641,082            
Ending balance at Mar. 31, 2021 2,478,649     $ 367,641     43,005,506     (40,894,498)
Beginning balance (in shares) at Dec. 31, 2020       288,074,415            
Beginning balance at Dec. 31, 2020 450,786     $ 288,074     38,896,693     (38,733,981)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net loss (4,184,544)                  
Ending balance (in shares) at Jun. 30, 2021       396,080,666            
Ending balance at Jun. 30, 2021 2,271,104     $ 396,081     44,793,548     (42,918,525)
Beginning balance (in shares) at Mar. 31, 2021       367,641,082            
Beginning balance at Mar. 31, 2021 2,478,649     $ 367,641     43,005,506     (40,894,498)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation expense 111,699           111,699      
Exercise of common stock options (in shares)       106,250            
Exercise of common stock options 4,783     $ 107     4,676      
Exercise warrant (in shares)         28,333,334          
Exercise warrant   $ 1,700,000     $ 28,333     $ 1,671,667    
Net loss (2,024,027)                 (2,024,027)
Ending balance (in shares) at Jun. 30, 2021       396,080,666            
Ending balance at Jun. 30, 2021 2,271,104     $ 396,081     44,793,548     (42,918,525)
Beginning balance (in shares) at Dec. 31, 2021       476,108,445            
Beginning balance at Dec. 31, 2021 5,864,166     $ 476,108     52,644,221     (47,256,163)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation expense (in shares)       150,000            
Stock-based compensation expense 150,358     $ 150     150,208      
Exercise warrant     $ 1,967     $ 19,667     $ (17,700)  
Net loss (3,043,399)                 (3,043,399)
Ending balance (in shares) at Mar. 31, 2022       495,925,112            
Ending balance at Mar. 31, 2022 2,973,092     $ 495,925     52,776,729     (50,299,562)
Beginning balance (in shares) at Dec. 31, 2021       476,108,445            
Beginning balance at Dec. 31, 2021 $ 5,864,166     $ 476,108     52,644,221     (47,256,163)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Exercise of common stock options (in shares) 0                  
Exercise warrant (in shares)     19,666,667     19,666,667        
Net loss $ (6,462,677)                  
Ending balance (in shares) at Jun. 30, 2022       495,925,112            
Ending balance at Jun. 30, 2022 (301,822)     $ 495,925     52,921,093     (53,718,840)
Beginning balance (in shares) at Mar. 31, 2022       495,925,112            
Beginning balance at Mar. 31, 2022 2,973,092     $ 495,925     52,776,729     (50,299,562)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation expense 144,364           144,364      
Net loss (3,419,278)                 (3,419,278)
Ending balance (in shares) at Jun. 30, 2022       495,925,112            
Ending balance at Jun. 30, 2022 $ (301,822)     $ 495,925     $ 52,921,093     $ (53,718,840)